Edmonds Duncan Registered Investment Advisors, LLC Horizon Therapeutics Public LTD CO Transaction History

Edmonds Duncan Registered Investment Advisors, LLC

$410 Million
Q2 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	BUY	$86.42 - $109.81 $16,419 - $20,863	190 Added 6.84%	2,969 $312,000
Q4 2021 Jan 27, 2022	BUY	$98.56 - $119.91 $2,365 - $2,877	24 Added 0.87%	2,779 $245,000
Q3 2021 Oct 19, 2021	BUY	$91.91 - $110.37 $10,569 - $12,692	115 Added 4.36%	2,755 $302,000
Q2 2021 Jul 27, 2021	BUY	$86.24 - $95.92 $2,500 - $2,781	29 Added 1.11%	2,640 $247,000
Q1 2021 May 06, 2021	BUY	$71.83 - $95.48 $4,956 - $6,588	69 Added 2.71%	2,611 $240,000
Q4 2020 Feb 19, 2021	BUY	$67.0 - $84.39 $170,314 - $214,519	2,542 New	2,542 $221,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmonds Duncan Registered Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edmonds Duncan Registered Investment Advisors, LLC with notifications on news.

Account